… , may represent a clinical biomarker to predict the efficacy of the treatment. The aim of this …
2 to 4 were correlated with response to treatment with bevacizumab in first line, as well as with …

… Among patients treated with first-line BEV, the predictors of survival have not yet been
discovered. However, the development of arterial hypertension has been correlated with …

… the correlation between BP changes and progression‐free (PFS) and overall survival (OS) …
conducted in the setting of first‐line metastatic colorectal cancer with 5‐fluorouracil based …

… Arterial hypertension (AHT) is a common toxicity with bevacizumab (BVZ)-containing …
Once we could not correlate the AHT, with PFS to CT/BVZ, we evaluated several cut-offs of …

… the clinical outcomes of bevacizumab combined with different backbone chemotherapies in
first-line mCRC treatment in Chinese oncology … a strong correlation between bevacizumab …

… In conclusion, our study demonstrates that the response, PFS, and OS of mCRC patients
treated with first-line FOLFIRI+bevacizumab regimen may be significantly influenced by the …

… bevacizumab-induced arterial hypertension may correlate with clinical outcome in colorectal
cancer patients … of six large randomised controlled trials of bevacizumab in combination with …

… cetuximab and bevacizumab we excluded patients treated in arm B … Arterial hypertension
correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab…

… start of the initial first-line bevacizumab-containing therapy to … the start of the first-line
bevacizumab-containing therapy to … patients alive 12 months after starting first-line bevacizumab-…

… colorectal cancer treated with bevacizumab as first-line … correlation between proteinuria
and clinical outcome in a consecutive series of patients with metastatic colorectal cancer treated …